SpringWorks Therapeutics
Latest round
- Series B
Last raised
- Mar 2019
Total raised
- $116M
Investors
- 13
About SpringWorks Therapeutics
SpringWorks Therapeutics, LLC is a biopharmaceutical company focused on treating rare oncology conditions, established in 2017 in Stamford, US.SpringWorks Therapeutics specializes in developing innovative treatments for rare oncology conditions, focusing primarily on precision oncology. Their core product offerings include nirogacestat, a gamma secretase inhibitor evaluated in multiple combination therapy regimens for B-cell maturation-related conditions.98 mn.30 mn to expand its oncology programs and advance late-stage rare disease oncology programs towards potential regulatory approval and commercialization. The company aims to launch new therapeutic products, specifically targeting expansion in the United States and Europe. With an emphasis on regulatory advancements, SpringWorks anticipates increasing its market presence and enhancing treatment options for patients suffering from rare oncological conditions.
Who invested in SpringWorks Therapeutics
13 investors across 2 rounds
See all investors in SpringWorks Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SpringWorks Therapeutics
Who invested in SpringWorks Therapeutics?
SpringWorks Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SpringWorks Therapeutics raised?
SpringWorks Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did SpringWorks Therapeutics last raise money?
SpringWorks Therapeutics's most recent round on record is a Series B, in Mar 2019.
What does SpringWorks Therapeutics do?
SpringWorks Therapeutics, LLC is a biopharmaceutical company focused on treating rare oncology conditions, established in 2017 in Stamford, US.
Where is SpringWorks Therapeutics headquartered?
SpringWorks Therapeutics is headquartered in Stamford, US.
Which VCs invest in companies like SpringWorks Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SpringWorks Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like SpringWorks Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.